[Interferon production in human T lymphoblastoid cells]. 1982

J Imanishi, and S Hoshino, and H Matsuoka, and M Kita, and J Minowada, and T Kishida

Human T lymphoblastoid cell (RPMI 8402 cell) produced interferon (IFN) through the induction by Sendai virus. The priming effect on the interferon production in the RPMI 8402 cell could be found by the pretreatment of human leukocyte IFN (Hu IFN-alpha), but not by that of the IFN produced in the RPMI 8402 cell (T-IFN). The superinduction by the irradiation of ultraviolet rays or the treatment of antimetabolites (actinomycin D and cycloheximide) or 5-bromodeoxyuridine was not found. The T-IFN was completely neutralized by the anti-Hu IFN-beta serum, but not by the anti-Hu IFN-alpha serum at all. In conclusion, it was confirmed that the IFN produced in the RPMI 8402 cell through the induction by Sendai virus was antigenically identical to Hu IFN-beta.

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010222 Parainfluenza Virus 1, Human A species of RESPIROVIRUS also called hemadsorption virus 2 (HA2), which causes laryngotracheitis in humans, especially children. Hemadsorption Virus 2,Human parainfluenza virus 1,Para-Influenza Virus Type 1,Parainfluenza Virus Type 1,Para Influenza Virus Type 1
D001973 Bromodeoxyuridine A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors. BUdR,BrdU,Bromouracil Deoxyriboside,Broxuridine,5-Bromo-2'-deoxyuridine,5-Bromodeoxyuridine,NSC-38297,5 Bromo 2' deoxyuridine,5 Bromodeoxyuridine,Deoxyriboside, Bromouracil
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003513 Cycloheximide Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. Actidione,Cicloheximide
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune

Related Publications

J Imanishi, and S Hoshino, and H Matsuoka, and M Kita, and J Minowada, and T Kishida
January 1978, Journal of clinical microbiology,
J Imanishi, and S Hoshino, and H Matsuoka, and M Kita, and J Minowada, and T Kishida
January 1977, Texas reports on biology and medicine,
J Imanishi, and S Hoshino, and H Matsuoka, and M Kita, and J Minowada, and T Kishida
January 1975, Journal of clinical microbiology,
J Imanishi, and S Hoshino, and H Matsuoka, and M Kita, and J Minowada, and T Kishida
January 1978, Advances in experimental medicine and biology,
J Imanishi, and S Hoshino, and H Matsuoka, and M Kita, and J Minowada, and T Kishida
January 1981, Texas reports on biology and medicine,
J Imanishi, and S Hoshino, and H Matsuoka, and M Kita, and J Minowada, and T Kishida
January 1986, Methods in enzymology,
J Imanishi, and S Hoshino, and H Matsuoka, and M Kita, and J Minowada, and T Kishida
May 1982, The Journal of general virology,
J Imanishi, and S Hoshino, and H Matsuoka, and M Kita, and J Minowada, and T Kishida
January 1981, Methods in enzymology,
J Imanishi, and S Hoshino, and H Matsuoka, and M Kita, and J Minowada, and T Kishida
February 1982, Infection and immunity,
J Imanishi, and S Hoshino, and H Matsuoka, and M Kita, and J Minowada, and T Kishida
December 1980, Cancer treatment reviews,
Copied contents to your clipboard!